A detailed history of Wynn Capital, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Wynn Capital, LLC holds 23,014 shares of PFE stock, worth $629,663. This represents 0.44% of its overall portfolio holdings.

Number of Shares
23,014
Previous 21,014 9.52%
Holding current value
$629,663
Previous $588 Million 13.28%
% of portfolio
0.44%
Previous 0.43%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$27.7 - $31.39 $55,400 - $62,780
2,000 Added 9.52%
23,014 $666 Million
Q2 2024

Jul 18, 2024

BUY
$25.26 - $29.6 $32,459 - $38,036
1,285 Added 6.51%
21,014 $588 Million
Q1 2024

Apr 10, 2024

SELL
$25.89 - $29.73 $43,857 - $50,362
-1,694 Reduced 7.91%
19,729 $547 Million
Q4 2023

Feb 01, 2024

BUY
$26.13 - $33.94 $559,782 - $727,096
21,423 New
21,423 $617 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Wynn Capital, LLC Portfolio

Follow Wynn Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wynn Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wynn Capital, LLC with notifications on news.